Home » Topics » Regulatory » Patents

Patents
RSS

Polycomb protein EED inhibitors discovered at Shanghai Blueray Biopharma

Aug. 20, 2020

University of Queensland, Preveceutical Medical patent delta- and kappa-opioid receptor antagonists

Aug. 19, 2020

Zhejiang Hisun Pharmaceutical presents new RET inhibitors

Aug. 19, 2020

Jiangsu Vcare Pharmatech discovers JAK inhibitors

Aug. 19, 2020

New PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors patented by Betta Pharmaceuticals

Aug. 19, 2020

BrightGene Bio-Medical Technology identifies Gly12Cys mutant GTPase KRAS inhibitors

Aug. 19, 2020

CSPC Zhongqi Pharmaceutical Technology describes PROTAC BRD4 degradation inducers

Aug. 18, 2020

New MAP2K1 inhibitors patented by Betta Pharmaceuticals

Aug. 18, 2020

Gargamel (Zhuhai) Biotech discovers JAK-1 inhibitors

Aug. 18, 2020

New CACNA2D ligands discovered at Sichuan Haisco Pharmaceutical

Aug. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...